Loading...
Shanghai Bio-heart Biological Technology Co., Ltd.
2185.HK•HKSE
Healthcare
Biotechnology
HK$4.10
HK$-0.09(-2.15%)
Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Financial Performance & Income Statement Overview
Review Shanghai Bio-heart Biological Technology Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
62.92%
↑ 62.92%
Net Income Growth
54.75%
↑ 54.75%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-12.72%
↓ 12.72%
ROIC
-8.55%
↓ 8.55%
Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK) Income Statement & Financial Overview
Review Shanghai Bio-heart Biological Technology Co., Ltd.'s (2185.HK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $9.75M | $9.75M | $10.89M | $10.91M |
| SG&A Expenses | $6.33M | $6.33M | $3.54M | $3.55M |
| Operating Expenses | $16.08M | $16.08M | $14.43M | $14.45M |
| Total Costs & Expenses | $16.08M | $16.08M | $14.43M | $14.45M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4.12M | $1.70M | $1.70M | $1.70M |
| EBITDA | -$11.96M | -$14.38M | -$12.73M | -$12.75M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$16.08M | -$16.08M | -$14.43M | -$14.45M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$16.42M | -$16.42M | $274869.00 | $275271.00 |
| Income Before Tax | -$32.50M | -$32.50M | -$14.16M | -$14.18M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | $0.00 | $1.06M | -$1.25M |
| Net Income | -$31.06M | -$31.06M | -$12.91M | -$12.93M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.13 | -$0.13 | -$0.06 | -$0.05 |
| Diluted EPS | -$0.13 | -$0.13 | -$0.06 | -$0.05 |
| Weighted Avg Shares Outstanding | $243.42M | $243.42M | $243.42M | $243.42M |
| Weighted Avg Shares Outstanding (Diluted) | $243.42M | $243.42M | $243.42M | $243.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan